Rezolute kol event highlights significant unmet medical need in diabetic macular edema

Rz402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor (anti-vegf) injections into the eye rz402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor (anti-vegf) injections into the eye
RZLT Ratings Summary
RZLT Quant Ranking